Document is current
Any future updates will be listed below
-
Authors
Dysoley, Lek
Cassidy-Seyoum, Sarah
Adhikari, Bipin
Dahal, Aaryan
Phoumen, Nead
Srey, Sin
Phalla, Touch
Vonn, Prak
Engrkruy, But
Sovanarath, Oum
Mengkea, Hor
Rathana, Pov
Makara, Iv
Heng, Pen Kim
Heng, Yim
Khlok, Huot
Pong, Khourn
Moeng, Tov
Vantha, Sam
Soviet, Ung
Ravuth, Rin
Bunreth, Voeurng
Vannak, Keo
Sokhann, Ma
Kimmen, Ke
Dy, Khoy
Samol, Siv
Lo, Koung
Sokunthea, Nuon
Kry, Hok
Kanha, Ly
Naren, Leng
Oum, Sarith
Sovann, Yok
Channavuth, Ros
Bunmeng, Chhun
Hughes, Jayme
Brindle, Hannah
Hu, Yang
Peng, Sovann
Mardi, Prum
Chanry, Im
Preap, Sodavuth
Heoy, Socheat
Sabawoon, Farooq
Sokha, Thoang
Ringwald, Pascal
Lynch, Caroline A.
Price, Ric N.
Tripura, Rupam
von Seidlein, Lorenz
Devine, Angela
Thriemer, Kamala
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (1182950)
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 21 November 2025
First Online: 3 January 2026
Declarations
:
: LD is a member of the Cambodian national treatment guideline committees. AD and RNP participated in the World Health Organization Guideline Development Group on near-patient G6PD tests to support safe and effective P. vivax anti-relapse treatment. PR is a staff member of WHO. The author alone is responsible for the views expressed in this publication, which do not necessarily represent the decisions, policies, or views of WHO.
